Acacia Pharma Group News & Analysen

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen
			Ausblick

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

Ausblick

26.02.21	Acacia Pharma Group plc : Transparency Notification (Investegate)
26.02.21	Acacia Pharma Group plc : Issue of Equity on Exercise of Options/Vesting of Performance Share Awards (Investegate)
23.02.21	Acacia Pharma Group plc : Admission to Trading on Euronext Brussels (Investegate)
19.02.21	Acacia Pharma Group plc : Results of Placing – EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities (Investegate)
18.02.21	Acacia Pharma Group plc : Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS® (Investegate)
18.02.21	Acacia Pharma Group plc : Change of EU home Member State (Investegate)
12.02.21	Acacia Pharma Group plc : Issue of Equity on Exercise of Options/Vesting of Performance Share Awards (Investegate)
04.02.21	Acacia Pharma Group plc : Issue of Equity on Exercise of Options/Vesting of Performance Share Awards (Investegate)
28.01.21	Acacia Pharma Group plc : Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less (Investegate)
21.01.21	Acacia Pharma Group plc : Acacia Pharma to present at the Upcoming Degroof Petercam Virtual Healthcare Conference (Investegate)
20.01.21	Acacia Pharma Group plc : Issue of Equity on Exercise of Options/Vesting of Performance Share Awards (Investegate)
20.01.21	Acacia Pharma Group plc : Acacia Pharma wins BEL Small Company of the Year for the second consecutive year (Investegate)
18.12.20	Acacia Pharma Group plc : Holding(s) in Company (Investegate)
18.12.20	Acacia Pharma Group plc : Admission to Trading on Euronext Brussels (Investegate)
17.12.20	Acacia Pharma Group plc : Publication of Supplementary Prospectus (Investegate)
15.12.20	Acacia Pharma Group plc : Correction: Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ (Investegate)
15.12.20	Acacia Pharma Group plc : Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ (Investegate)
13.10.20	Acacia Pharma Group plc : Director/PDMR Shareholding (Investegate)
13.10.20	Acacia Pharma Group plc : Issue of Shares to Employee Benefit Trust (Investegate)
24.08.20	Acacia Pharma Group plc : BARHEMSYS® (amisulpride injection) Launched in the US for the Treatment and Prevention of PONV (Investegate)
19.08.20	Acacia Pharma Group plc : Holding(s) in Company (Investegate)
18.08.20	Acacia Pharma Group plc : Admission to Trading on Euronext Brussels (Investegate)
14.08.20	Acacia Pharma Group plc : Publication of Prospectus (Investegate)
14.08.20	Acacia Pharma Group plc : Results of Placing (Investegate)
13.08.20	Acacia Pharma Group plc : Proposed Capital Raising by way of a Placing of New Ordinary Shares (Investegate)
13.08.20	Acacia Pharma Group plc : Interim Results for the Six Months ended 30 June 2020 (Investegate)
27.07.20	Acacia Pharma Group plc : Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® (Investegate)
21.07.20	Acacia Pharma Group plc : Holding(s) in Company (Investegate)
16.07.20	Acacia Pharma Group plc : Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies (Investegate)
15.07.20	Acacia Pharma Group plc : Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV (Investegate)
07.09.18	Edison Investment Research Limited: Edison issues initiation on Acacia Pharma (ACPH) (EQS Group)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	14.48	0.21 %
Swisscom	466.70	0.06 %
Nestle	98.44	-0.06 %
Sika	251.20	-0.32 %
CS Group	12.92	-0.39 %
Part Grp Hldg	1’107.00	-1.29 %
Swiss Re	88.68	-1.47 %
Swiss Life Hldg	448.40	-1.47 %
SGS	2’610.00	-1.51 %
Zurich Insur Gr	388.20	-1.82 %

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Acacia Pharma Group Limited Registered Shs 144A

Eintrag hinzufügen Eintrag bearbeiten

Aktien Top/Flop

Meistgelesene Nachrichten